Acadia Pharma GAAP EPS of $0.16 beats by $0.03, revenue of $264.6M beats by $2.6M

Posted on by wpadmin
  • Acadia Pharma press release (NASDAQ:ACAD): Q2 GAAP EPS of $0.16 beats by $0.03.
  • Revenue of $264.6M (+9.4% Y/Y) beats by $2.6M.
  •  

Leave a Reply

Your email address will not be published. Required fields are marked *